期刊文献+

急性冠脉综合征患者肌钙蛋白和低密度脂蛋白氧化修饰延滞时间检测的临床意义 被引量:2

Clinical Significance of Analysis cTnI and Delay Time of ox-LDL in Acute Coronary Syndrome
下载PDF
导出
摘要 目的 探讨肌钙蛋白(cTnI)和低密度脂蛋白氧化修饰期联合检测在诊断急性冠脉综合征(ACS)患者病变程度中的价值.方法 采用共扼双烯(CD)法测定低密度脂蛋白氧化修饰期,胶乳增强免疫比浊法测定cTnI,经检测ACS患者80例,其中急性心肌梗死(AMI)30例、不稳定性心绞痛(UAP)20例、稳定心绞痛(SAP)患者30例,并与正常对照组40例比较.结果 ACS不同病变程度组即急性心肌梗死组、不稳定性心绞痛组和稳定性心绞痛组患者与对照组cTnI含量和LDL氧化修饰期参数差异有统计学意义(t=10.24,15.48,22.49,P<0.01;t=32.76,25.35,22.05,P<0.01).而急性心肌梗死组和不稳定性心绞痛组cTnI含量差异无统计学意义(t=0.879,P>0.05),LDL氧化修饰延滞时间在上述两组间差异有统计学意义(t=8.476,P<0.05).结论 ACS患者联合检测cTnI和LDL氧化修饰期的变化,可界定ACS病变程度. Objective To discuss the significant of analysis cTnI and delay time of ox-LDL in acute coronary syndrome (ACS). Methods Serum from 80 patients with acute eoronary syndrome,eluding in AMI 30 eases, UAP 30 cases,SAP 30 cases and 40 healthy controls, were determined cTnI and delay time of ox-LDL by CD methods and hematopexis equipment seperately. Results Patients with acute coronary syndrome (ACS) had higher eases of cTnI,lower level of delay time of oxLDL,than healthy controls (t= 10. 24,t= 15.48,t=22.49,P〈0.01;t= 32. 76,t=25.35,t=22.05,P〈0. 01). However, the level in AMI and UAP had no difference (t=0. 879,P〈0. 05). The difference of delay time in ox-LDL was significant between AMI and UAP (t=8. 476,P〈2005). Conclusion cTnI and delay time of ox-LDL may be a useful factor for diagnosis acute coronary syndrome (ACS).
出处 《现代检验医学杂志》 CAS 2013年第3期135-137,共3页 Journal of Modern Laboratory Medicine
关键词 低密度脂蛋白氧化修饰期 急性冠脉综合征(ACS) 肌钙蛋白(cTnI) delay time in ox-LDL acute coronary syndrome cTnI
  • 相关文献

参考文献5

二级参考文献34

  • 1于立宏,田刚,王金良.氧化低密度脂蛋白与2型糖尿病动脉粥样硬化关系的探讨[J].天津医科大学学报,2004,10(2):248-250. 被引量:1
  • 2Lavi S , McConnell JP, Prasad A, et al. Local production of lipoprotein- associated phospholipase A2 and lysophosphatidylcholine in the coronary circulatio n: association with early coronary atherosclerasis and endothelial dysfunction in Humans [J]. Circulation , 2007 , 115 (21) : 2 715-721.
  • 3Lanman RB, Wolfert RL, Fleming JK, et al. Lipoprotein-associated phospholipase A2 : review and recommendation of a clinical cut point for adults [J]. Prevent Cardiol, 2006, 9 (3) : 138-143.
  • 4Gazi I, Lourida ES, Filippatos T, et al. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma [ J ]. Clinic Chemistry, 2005,51 (12) : 2 264-273.
  • 5Brilakis ES, Khera A, McGulre DK, et al. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the dallas heart study [J]. Atherosclerosis, 2008, 199 (1) : 110-115.
  • 6Vinson A, Mahaney MC, Cox LA, et al. A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors [ J ]. Atherosclerosis, 2008, 196 (2) : 6674S73.
  • 7Mertens A, Verhamme P, Bielicki JK, et al. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice [ J ]. Circulation, 2003, 107 (12) : 1 640-646.
  • 8Singh U, Zhong S, Xiong M, et al. Increased plasma non-esterliqed fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice [ J ]. Clinic Sci (Lond), 2004, 106 (4) : 421-432.
  • 9Tsirnikas S, Tsironis LD, Tselepis AD. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease [ J ]. Arterioscler Thromb Vas Biol, 2007, 27 (10) : 2 0944)99.
  • 10Tsironis LD, Katsouras CS, Lourida ES, et al. Reduced PAF-acetylhydrolase activity associated with Lp (a) in patients with coronary artery disease [ J]. Atherosclerosis, 2004, 177 (1): 193-201.

共引文献26

同被引文献25

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部